Description

AMLOHEAL AT TAB

Indications

AMLOHEAL AT TAB is primarily indicated for the management of hypertension and certain types of angina pectoris. It is often prescribed as a first-line treatment for patients with high blood pressure, helping to reduce the risk of cardiovascular events such as stroke and heart attack. Additionally, AMLOHEAL AT TAB may be utilized in patients with chronic stable angina to improve exercise tolerance and reduce the frequency of angina episodes.

Mechanism of Action

AMLOHEAL AT TAB combines two active ingredients: amlodipine and atenolol. Amlodipine is a calcium channel blocker that works by inhibiting the influx of calcium ions into vascular smooth muscle and cardiac muscle, leading to vasodilation and a decrease in peripheral vascular resistance. This results in lowered blood pressure and reduced workload on the heart. Atenolol, a selective beta-1 adrenergic blocker, decreases heart rate and myocardial contractility, further contributing to the reduction of blood pressure and the oxygen demand of the heart. Together, these mechanisms provide a synergistic effect in managing hypertension and angina.

Pharmacological Properties

The pharmacokinetics of AMLOHEAL AT TAB reveal that amlodipine has a long half-life, allowing for once-daily dosing. It is well absorbed from the gastrointestinal tract, with peak plasma concentrations occurring approximately 6-12 hours after administration. Atenolol also exhibits good oral bioavailability and reaches peak plasma levels within 2-4 hours. Both drugs are metabolized in the liver, with atenolol primarily excreted unchanged in the urine. The combination of these two agents provides effective blood pressure control over a 24-hour period, making it suitable for once-daily administration.

Contraindications

AMLOHEAL AT TAB is contraindicated in patients with a known hypersensitivity to amlodipine, atenolol, or any of the excipients in the formulation. It should not be used in patients with severe bradycardia, heart block greater than first degree, cardiogenic shock, or decompensated heart failure. Additionally, caution is advised in patients with a history of asthma or chronic obstructive pulmonary disease (COPD) due to the beta-blocking effects of atenolol, which may cause bronchospasm.

Side Effects

Common side effects associated with AMLOHEAL AT TAB may include dizziness, fatigue, headache, and peripheral edema. Patients may also experience gastrointestinal disturbances such as nausea and abdominal discomfort. Less frequently, serious side effects such as bradycardia, hypotension, or allergic reactions may occur. It is important for patients to report any unusual or severe symptoms to their healthcare provider promptly. Regular monitoring of blood pressure and heart rate is recommended to ensure safety and efficacy during treatment.

Dosage and Administration

The recommended starting dose of AMLOHEAL AT TAB is typically one tablet taken orally once daily. The dosage may be adjusted based on the patient’s response to therapy and the presence of any side effects. It is essential to adhere to the prescribed regimen and not to discontinue the medication without consulting a healthcare professional. Patients should take the tablet at the same time each day to maintain consistent blood levels of the medication.

Interactions

AMLOHEAL AT TAB may interact with various medications, potentially altering their effects. Concomitant use of other antihypertensive agents may lead to additive hypotensive effects. Caution is advised when using AMLOHEAL AT TAB with medications that may affect heart rate or cardiac output, such as digoxin or other beta-blockers. Additionally, non-steroidal anti-inflammatory drugs (NSAIDs) may reduce the antihypertensive effect of AMLOHEAL AT TAB. Patients should inform their healthcare provider of all medications they are taking to avoid potential interactions.

Precautions

Before initiating treatment with AMLOHEAL AT TAB, a thorough medical history should be obtained, and any pre-existing conditions should be evaluated. Patients with renal or hepatic impairment may require dose adjustments and closer monitoring. Caution should also be exercised in patients with a history of heart failure or those with diabetes, as beta-blockers can mask the symptoms of hypoglycemia. Regular follow-up appointments are essential to monitor blood pressure, heart rate, and overall health during treatment.

Clinical Studies

Clinical studies have demonstrated the efficacy of AMLOHEAL AT TAB in reducing blood pressure and improving exercise tolerance in patients with hypertension and angina. In a randomized controlled trial, patients treated with the combination of amlodipine and atenolol showed significant reductions in systolic and diastolic blood pressure compared to those receiving monotherapy. Additionally, the combination therapy was well-tolerated, with a side effect profile similar to that of the individual components. These findings support the use of AMLOHEAL AT TAB as an effective treatment option for managing hypertension and angina pectoris.

Conclusion

AMLOHEAL AT TAB is a valuable therapeutic option for patients with hypertension and angina, combining the benefits of amlodipine and atenolol to achieve optimal blood pressure control and improve cardiovascular health. Its dual mechanism of action and favorable pharmacokinetic properties make it suitable for once-daily dosing, enhancing patient adherence to therapy. As with any medication, it is essential for patients to use AMLOHEAL AT TAB responsibly and under the guidance of a healthcare professional to ensure the best possible outcomes.